Owens, Eileen
Harris, Lauren
Harris, Adam
Yoshimoto, Janna
Burnett, Robert
Avery, Anne
Funding for this research was provided by:
National Institutes of Health (T32OD010437)
Article History
Received: 14 June 2023
Accepted: 14 December 2023
First Online: 2 January 2024
Declarations
:
: Tissue from dogs with PTCL submitted to the Colorado State University Clinical Hematopathology Laboratory for routine diagnostics was utilized for this study with informed consent from the dogs’ owners. study. Per our sample submission form, “all samples submitted to CSU Clinical Hematopathology become the property of Clinical Hematopathology for use in research and test development. All identifying information is removed for publication, presentation or submission to outside services for analysis.” Control lymph node, blood, and thymus samples were obtained from donated canine cadavers that had been previously euthanized at a contract research organization unaffiliated with our study, and all experimental protocols were approved by their institution’s IACUC. No live animals were utilized for any of the experiments in this study, and no animals were euthanized specifically for this study. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.
: Not applicable.
: The authors declare no competing interests.